Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1667686 Target Snapshot

Neuraminidase · SINGLE PROTEIN · Influenza A virus

19Compounds
8Assays
5Approved Drugs
28.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt C4LRQ6. Use UniProt C4LRQ6 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt C4LRQ6 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Neuraminidase as ChEMBL target CHEMBL1667686, mapped to UniProt C4LRQ6. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Neuraminidase
SINGLE PROTEIN · Influenza A virus
As of 2026-09-14
ChEMBL target ID
CHEMBL1667686
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
C4LRQ6
Neuraminidase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Neuraminidase is the right protein anchor across sources, using UniProt C4LRQ6 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelNeuraminidase
UniProt AccessionC4LRQ6
Component TypeProtein
Sequence Length449 aa

Neuraminidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Neuraminidase, mapped to UniProt C4LRQ6. Sequence length is 449 aa.

Mapped IDC4LRQ6
Review nameNeuraminidase
OrganismInfluenza A virus
Clinical Profile

Clinical Phase Distribution

5
Approved
Assay Mix

Activity Type Distribution

IC5026.0
KI2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1229 10.0 IC50 0.1 Approved
CHEMBL222813 9.3 Ki 0.5 Approved
CHEMBL222813 9.22 IC50 0.6 Approved
CHEMBL1229 8.96 Ki 1.1 Approved
CHEMBL139367 6.84 IC50 146.0 Approved
CHEMBL3342485 6.8 IC50 160.0 Preclinical
CHEMBL4161935 6.41 IC50 387.07 Preclinical
CHEMBL4288995 6.37 IC50 426.0 Preclinical
CHEMBL4288789 6.25 IC50 564.0 Preclinical
CHEMBL4175983 6.18 IC50 663.9 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
3
5.5
7
6.0
2
6.5
0
7.0
0
7.5
1
8.0
1
8.5
3
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PERAMIVIR ANHYDROUS
CHEMBL139367
Approved 2014
OSELTAMIVIR
CHEMBL1229
Approved 1999
ZANAMIVIR
CHEMBL222813
Approved 1999
Assay Landscape

Assay Landscape

8
Total Assays
18
Tested Compounds
1
Assay Types
Binding — 8 assays, 18 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 6 15 6.7
cell-based format 2 3 6.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine